TRPA1 Mediates Oxidized Phosphatidylcholine-Induced Inflammatory Mediator Expression in Human Airway Fibroblasts

The airways inside our lungs are lined with a delicate layer of cells that act as a barrier against the outside world. When we breathe in pollutants, smoke, or allergens, this barrier can become overwhelmed by a chemical chaos known as oxidative stress. Imagine the air inside our lungs as a busy highway; when too many cars (pollutants) enter at once, they cause collisions that damage the road surface. In the body, these collisions create reactive molecules that chemically alter the fats, or lipids, that make up the cell membranes. One specific type of damaged fat, called oxidized phosphatidylcholine, acts like a distress signal. It tells the body that something is wrong and triggers a cascade of reactions intended to fight the threat. However, in chronic conditions like asthma, this signal can become a constant alarm, leading to persistent inflammation and the thickening of airway walls, which makes breathing difficult.

Scientists have long known that these damaged fats play a role in airway disease, but the exact mechanism by which they communicate with the structural cells of the lung remained unclear. A team of researchers at the University of Manitoba and Tottori University set out to solve this puzzle by focusing on a specific type of cell called the airway fibroblast. These cells are the construction workers of the lung; they build the scaffolding that holds the airways open and help repair tissue after injury. The researchers wanted to know if these construction workers could also sense the distress signal from the damaged fats and, if so, how they would react. They suspected that a specific protein channel on the surface of the cell, known as TRPA1, might be the receiver for this signal. This channel is famous for its role in sensing pain and irritation in nerves, but its function in lung construction cells was a mystery.

To investigate this, the researchers took healthy lung tissue from donors who were undergoing surgery for non-cancerous reasons. From this tissue, they carefully isolated the airway fibroblasts and grew them in a laboratory dish. They then introduced the damaged fat, oxidized phosphatidylcholine, to these cells to see what would happen. The first thing they observed was a rapid surge in calcium inside the cells. In biological terms, calcium acts as a universal messenger; when it floods into a cell, it tells the cell to wake up and start working. The researchers found that this surge happened in two distinct waves: a quick spike followed by a sustained flow. By using a special chemical blocker that specifically shuts down the TRPA1 channel, they discovered that this channel was responsible for the vast majority of that calcium surge. Without TRPA1, the cells barely reacted to the damaged fat.

Once the calcium signal was established, the researchers looked at what the cells actually did in response. They measured the production of three specific inflammatory messengers: IL-6, IL-8, and COX-2. These are molecules that recruit immune cells to the area and can cause swelling and tissue changes. The results were striking. When exposed to the damaged fat, the fibroblasts dramatically increased their production of these messengers. IL-8 levels jumped more than thirty-fold, while IL-6 and COX-2 also rose significantly. Crucially, when the researchers blocked the TRPA1 channel, the production of these messenger molecules dropped by a large margin. This confirmed that the TRPA1 channel was a key switch that turned on the inflammatory response in these cells.

However, the story was not entirely simple. While blocking TRPA1 stopped the production of the genetic instructions for these messengers, it did not completely stop the cells from releasing the actual proteins into their surroundings. This suggests that while TRPA1 is essential for starting the alarm, the damaged fat likely uses other pathways to keep the factory running. The researchers also tested whether simply turning on the TRPA1 channel with a different chemical, one that is not a damaged fat, could recreate the full inflammatory response. It could not. The TRPA1 channel alone was enough to trigger one of the messengers, IL-6, but it failed to produce the full spectrum of inflammation seen when the damaged fat was present. This indicates that the damaged fat is a complex signal that engages multiple systems within the cell, with TRPA1 being just one critical part of a larger network.

The study also looked at whether this response differed between men and women, as biological sex can sometimes influence how cells react to stress. They analyzed cells from both male and female donors and found no difference in how the TRPA1 channels behaved or how the cells responded to the damaged fat. This suggests that the mechanism is a fundamental feature of airway fibroblasts, regardless of the donor's sex. The researchers concluded that oxidized phosphatidylcholine acts as a direct trigger for airway inflammation by activating the TRPA1 channel in fibroblasts, leading to a calcium surge that drives the production of inflammatory signals. While TRPA1 is a major player, the fact that the inflammatory response persists even when the channel is blocked implies that the lung has redundant safety mechanisms, or perhaps dangerous backup systems, that keep the inflammation going. This work provides a clearer picture of how environmental stressors can hijack the lung's own construction crew to fuel chronic disease, highlighting TRPA1 as a potential target for new therapies that could calm the airways without shutting down all cellular communication.